The PTEN and myotubularin phosphoinositide 3-phosphatases: Linking lipid signalling to human disease

Sub-Cellular Biochemistry

Volumn 58, Issue , 2012, Pages 281-336

  Davies, Elizabeth M ^b   Sheffield, David A ^b   Tibarewal, Priyanka ^a   Fedele, Clare G ^b   Mitchell, Christina A ^b   Leslie, Nicholas R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Myotubularin; Phosphatase; Phosphoinositide; PI 3 kinase; PTEN

Indexed keywords

MYOTUBULARIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 PHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; PHOSPHATIDYLINOSITOL 3,5 DIPHOSPHATE; PHOSPHATIDYLINOSITOL 3,5-DIPHOSPHATE; POLYPHOSPHOINOSITIDE; PTEN PROTEIN, HUMAN;

ARTICLE; ENZYME SPECIFICITY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HYDROLYSIS; METABOLISM; MUTATION; MYOPATHY; PATHOLOGY; PHOSPHORYLATION; SECOND MESSENGER;

CHARCOT-MARIE-TOOTH DISEASE; GENE EXPRESSION REGULATION; HUMANS; HYDROLYSIS; MUTATION; MYOPATHIES, STRUCTURAL, CONGENITAL; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; PTEN PHOSPHOHYDROLASE; SECOND MESSENGER SYSTEMS; SUBSTRATE SPECIFICITY;

EID: 84875779894     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-007-3012-0_8     Document Type: Article

References (325)

1. Agrawal, S, Eng, C (2006) Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer. Hum Mol Genet 15: pp. 777-787
2. Al-Qusairi, L, Weiss, N, Toussaint, A, Berbey, C, Messaddeq, N, Kretz, C, Sanoudou, D, Beggs, AH, Allard, B, Mandel, JL, Laporte, J, Jacquemond, V, Buj-Bello, A (2009) T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc Natl Acad Sci USA 106: pp. 18763-18768
3. Alimonti, A, Nardella, C, Chen, Z, Clohessy, JG, Carracedo, A, Trotman, LC, Cheng, K, Varmeh, S, Kozma, SC, Thomas, G, Rosivatz, E, Woscholski, R, Cognetti, F, Scher, HI, Pandolfi, PP (2010) A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J Clin Invest 120: pp. 681-693
4. Alonso, A, Sasin, J, Bottini, N, Friedberg, I, Osterman, A, Godzik, A, Hunter, T, Dixon, J, Mustelin, T (2004) Protein tyrosine phosphatases in the human genome. Cell 117: pp. 699-711
5. Anezaki, Y, Ohshima, S, Ishii, H, Kinoshita, N, Dohmen, T, Kataoka, E, Sato, W, Iizuka, M, Goto, T, Sasaki, J, Sasaki, T, Suzuki, A, Ohnishi, H, Horie, Y (2009) Sex difference in the liver of hepatocyte-specific Pten-deficient mice: a model of nonalcoholic steatohepatitis. Hepatol Res 39: pp. 609-618
6. Anzelon, AN, Wu, H, Rickert, RC (2003) Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol 4: pp. 287-294
7. Azzedine, H, Bolino, A, Taieb, T, Birouk, N, Di, DUCA M, Bouhouche, A, Benamou, S, Mrabet, A, Hammadouche, T, Chkili, T, Gouider, R, Ravazzolo, R, Brice, A, Laporte, J, Leguern, E (2003) Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am J Hum Genet 72: pp. 1141-1153
8. Backman, SA, Stambolic, V, Suzuki, A, Haight, J, Elia, A, Pretorius, J, Tsao, MS, Shannon, P, Bolon, B, Ivy, GO, Mak, TW (2001) Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease. Nat Genet 29: pp. 396-403
9. Backman, SA, Ghazarian, D, So, K, Sanchez, O, Wagner, KU, Hennighausen, L, Suzuki, A, Tsao, MS, Chapman, WB, Stambolic, V, Mak, TW(2004) Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci USA 101: pp. 1725-1730
10. Bandaru, SS, Lin, K, Roming, SL, Vellipuram, R, Harney, JP (2009) Effects of PI3K inhibition and low docosahexaenoic acid on cognition and behavior. Physiol Behav 100: pp. 239-244
11. Beggs, AH, Bohm, J, Snead, E, Kozlowski, M, Maurer, M, Minor, K, Childers, MK, Taylor, SM, Hitte, C, Mickelson, JR, Guo, LT, Mizisin, AP, Buj-Bello, A, Tiret, L, Laporte, J, Shelton, GD (2010) MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers. Proc Natl Acad Sci USA 107: pp. 14697-14702
12. Begley, MJ, Taylor, GS, Kim, S-A, Veine, DM, Dixon, JE, Stuckey, JA (2003) Crystal structure of a phosphoinositide phosphatase, MTMR2: insights into myotubular myopathy and Charcot-Marie-Tooth syndrome. Mol Cell 12: pp. 1391
13. Begley, MJ, Taylor, GS, Brock, MA, Ghosh, P, Woods, VL, Dixon, JE (2006) Molecular basis for substrate recognition by MTMR2, a myotubularin family phosphoinositide phosphatase. Proc Natl Acad Sci USA 103: pp. 927-932
14. Berger, P, Bonneick, S, Willi, S, Wymann, M, Suter, U (2002) Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. Hum Mol Genet 11: pp. 1569-1579
15. Berger, P, Schaffitzel, C, Berger, I, Ban, N, Suter, U (2003) Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. Proc Natl Acad Sci USA 100: pp. 12177-12182
16. Berger, P, Berger, I, Schaffitzel, C, Tersar, K, Volkmer, B, Suter, U (2006) Multi-level regulation of myotubularin-related protein-2 (mtmr2) phosphatase activity by myotubularin-related protein-13/set-binding factor-2 (MTMR13/SBF2). Hum Mol Genet 15: pp. 569-579
17. Berger P, Tersar K, Ballmer-Hofer K, Suter U (2011) The CMT4B disease-causing proteins MTMR2 and MTMR13/SBF2 regulate AKT signaling. J Cell Mol Med 15:307–315
18. Biancalana, V, Caron, O, Gallati, S, Baas, F, Kress, W, Novelli, G, D’Apice, MR, Lagier-Tourenne, C, Buj-Bello, A, Romero, NB, Mandel, JL(2003) Characterisation of mutations in 77 patients with X-linked myotubular myopathy, including a family with a very mild phenotype. Hum Genet 112: pp. 135-142
19. Blondeau, F, Laporte, J, Bodin, S, Superti-Furga, G, Payrastre, B, Mandel, J-L (2000) Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum Mol Genet 9: pp. 2223-2229
20. Bolino, A, Muglia, M, Conforti, FL, Leguern, E, Salih, MA, Georgiou, DM, Christodoulou, K, Hausmanowa-Petrusewicz, I, Mandich, P, Schenone, A, Gambardella, A, Bono, F, Quattrone, A, Devoto, M, Monaco, AP (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25: pp. 17-19
21. Bolino, A, Bolis, A, Previtali, SC, Dina, G, Bussini, S, Dati, G, Amadio, S, Carro, U, Mruk, DD, Feltri, ML, Cheng, CY, Quattrini, A, Wrabetz, L (2004) Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis. J Cell Biol 167: pp. 711-721
22. Bolis, A, Coviello, S, Bussini, S, Dina, G, Pardini, C, Previtali, SC, Malaguti, M, Morana, P, Del Carro, U, Feltri, ML, Quattrini, A, Wrabetz, L, Bolino, A (2005) Loss of Mtmr2 phosphatase in Schwann cells but not in motor neurons causes Charcot-Marie-Tooth type 4B1 neuropathy with myelin outfoldings. J Neurosci 25: pp. 8567-8577
23. Bolis, A, Coviello, S, Visigalli, I, Taveggia, C, Bachi, A, Chishti, AH, Hanada, T, Quattrini, A, Previtali, SC, Biffi, A, Bolino, A (2009) Dlg1, Sec8, and Mtmr2 regulate membrane homeostasis in Schwann cell myelination. J Neurosci 29: pp. 8858-8870
24. Bonifati, V, Rizzu, P, BAREN, MJ, Schaap, O, Breedveld, GJ, Krieger, E, Dekker, MC, Squitieri, F, Ibanez, P, Joosse, M, Dongen, JW, Vanacore, N, Swieten, JC, Brice, A, Meco, G, Duijn, CM, Oostra, BA, Heutink, P (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: pp. 256-259
25. Bonneick, S, Boentert, M, Berger, P, Atanasoski, S, Mantei, N, Wessig, C, Toyka, KV, Young, P, Suter, U (2005) An animal model for Charcot-Marie-Tooth disease type 4B1. Hum Mol Genet 14: pp. 3685-3695
26. Buj-Bello, A, Furling, D, Tronchere, H, Laporte, J, Lerouge, T, Butler-Browne, GS, Mandel, JL (2002a) Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum Mol Genet 11: pp. 2297-2307
27. Buj-Bello, A, Laugel, V, Messaddeq, N, Zahreddine, H, Laporte, J, Pellissier, J-F, Mandel, J-L (2002b) The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc Natl Acad Sci USA 99: pp. 15060-15065
28. Buj-Bello, A, Fougerousse, F, Schwab, Y, Messaddeq, N, Spehner, D, Pierson, CR, Durand, M, Kretz, C, Danos, O, Douar, AM, Beggs, AH, Schultz, P, Montus, M, Denefle, P, Mandel, JL (2008) AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis. Hum Mol Genet 17: pp. 2132-2143
29. Cairns, P, Okami, K, Halachmi, S, Halachmi, N, Esteller, M, Herman, JG, Jen, J, Isaacs, WB, Bova, GS, Sidransky, D (1997) Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57: pp. 4997-5000
30. Campbell, RB, Liu, F, Ross, AH (2003) Allosteric activation of PTEN phosphatase by phosphatidylinositol 4,5-bisphosphate. J Biol Chem 278: pp. 33617-33620
31. Campisi, J, D’Adda Di Fagagna, F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: pp. 729-740
32. Cancer Genomeatlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: pp. 1061-1068
33. Cao, X, Wei, G, Fang, H, Guo, J, Weinstein, M, Marsh, CB, Ostrowski, MC, Tridandapani, S (2004) The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports Toll-like receptor 4 signaling in murine peritoneal macrophages. J Immunol 172: pp. 4851-4857
34. Cao, C, Laporte, J, Backer, JM, Wandinger-Ness, A, Stein, M-P (2007) Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase complex on endosomes. Traffic 8: pp. 1052-1067
35. Cao, C, Backer, JM, Laporte, J, Bedrick, EJ, Wandinger-Ness, A (2008) Sequential actions of myotubularin lipid phosphatases regulate endosomal PI(3)P and growth factor receptor trafficking. Mol Biol Cell 19: pp. 3334-3346
36. Carver, BS, Tran, J, Gopalan, A, Chen, Z, Shaikh, S, Carracedo, A, Alimonti, A, Nardella, C, Varmeh, S, Scardino, PT, Cordon-Cardo, C, Gerald, W, Pandolfi, PP (2009) Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 41: pp. 619-624
37. Chang, CJ, Freeman, DJ, Wu, H (2004) PTEN regulates Mdm2 expression through the P1 promoter. J Biol Chem 279: pp. 29841-29848
38. Chang, N, El-Hayek, YH, Gomez, E, Wan, Q (2007) Phosphatase PTEN in neuronal injury and brain disorders. Trends Neurosci 30: pp. 581-586
39. Chaussade, C, Pirola, L, Bonnafous, S, Blondeau, F, Brenz-Verca, S, Tronchere, H, Portis, F, Rusconi, S, Payrastre, B, Laporte, J, Obberghen, E (2003) Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol Endocrinol 17: pp. 2448-2460
40. Chen, Z, Trotman, LC, Shaffer, D, Lin, HK, Dotan, ZA, Niki, M, Koutcher, JA, Scher, HI, Ludwig, T, Gerald, W, Cordon-Cardo, C, Pandolfi, PP(2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: pp. 725-730
41. Chen, F, Archambault, V, Kar, A, Lio, P, D’Avino, PP, Sinka, R, Lilley, K, Laue, ED, Deak, P, Capalbo, L, Glover, DM (2007) Multiple protein phosphatases are required for mitosis in Drosophila. Curr Biol 17: pp. 293-303
42. Cheng, S, Hsia, CY, Feng, B, Liou, ML, Fang, X, Pandolfi, PP, Liou, HC (2009) BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten. Cell Res 19: pp. 196-207
43. Chojnowski, A, Ravise, N, Bachelin, C, Depienne, C, Ruberg, M, Brugg, B, Laporte, J, Baron-Van Evercooren, A, Leguern, E (2007) Silencing of the Charcot-Marie-Tooth associated MTMR2 gene decreases proliferation and enhances cell death in primary cultures of Schwann cells. Neurobiol Dis 26: pp. 323-331
44. Choudhury, P, Srivastava, S, Li, Z, Ko, K, Albaqumi, M, Narayan, K, Coetzee, WA, Lemmon, MA, Skolnik, EY (2006) Specificity of the myotubularin family of phosphatidylinositol-3-phosphatase is determined by the PH/GRAM domain. J Biol Chem 281: pp. 31762-31769
45. Chung, JH, Eng, C (2005) Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis. Cancer Res 65: pp. 8096-8100
46. Chung, JH, Ginn-Pease, ME, Eng, C (2005) Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res 65: pp. 4108-4116
47. Collado, M, Serrano, M (2010) Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10: pp. 51-57
48. Crackower, MA, Oudit, GY, Kozieradzki, I, Sarao, R, Sun, H, Sasaki, T, Hirsch, E, Suzuki, A, Shioi, T, Irie-Sasaki, J, Sah, R, Cheng, HY, Rybin, VO, Lembo, G, Fratta, L, Oliveira-Dos-Santos, AJ, Benovic, JL, Kahn, CR, Izumo, S, Steinberg, SF, Wymann, MP, Backx, PH, Penninger, JM (2002) Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110: pp. 737-749
49. Davidson, L, Maccario, H, Perera, NM, Yang, X, Spinelli, L, Tibarewal, P, Glancy, B, Gray, A, Weijer, CJ, Downes, CP, Leslie, NR (2010) Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN. Oncogene 29: pp. 687-697
50. Davies, MA, Lu, Y, Sano, T, Fang, X, Tang, P, Lapushin, R, Koul, D, Bookstein, R, Stokoe, D, Yung, WK, Mills, GB, Steck, PA (1998) Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res 58: pp. 5285-5290
51. Delgado-Esteban, M, Martin-Zanca, D, Andres-Martin, L, Almeida, A, Bolanos, JP (2007) Inhibition of PTEN by peroxynitrite activates the phosphoinositide-3-kinase/Akt neuroprotective signaling pathway. J Neurochem 102: pp. 194-205
52. Denning, G, Jean-Joseph, B, Prince, C, Durden, DL, Vogt, PK (2007) A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth. Oncogene 26: pp. 3930-3940
53. Dey, N, Crosswell, HE, De, P, Parsons, R, Peng, Q, Su, JD, Durden, DL (2008) The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration. Cancer Res 68: pp. 1862-1871
54. Cristofano, A, Pesce, B, Cordon-Cardo, C, Pandolfi, PP (1998) Pten is essential for embryonic development and tumour suppression. Nat Genet 19: pp. 348-355
55. Di Cristofano, A, Kotsi, P, Peng, YF, Cordon-Cardo, C, Elkon, KB, Pandolfi, PP (1999) Impaired Fas response and autoimmunity in Pten+/- mice. Science 285: pp. 2122-2125
56. Doerks, T, Strauss, M, Brendel, M, Bork, P (2000) GRAM, a novel domain in glucosyltransferases, myotubularins and other putative membrane-associated proteins. Trends Biochem Sci 25: pp. 483-485
57. Dolley, G, Lamarche, B, Despres, JP, Bouchard, C, Perusse, L, Vohl, MC (2009) Phosphoinositide cycle gene polymorphisms affect the plasma lipid profile in the Quebec Family Study. Mol Genet Metab 97: pp. 149-154
58. Dove, SK, Dong, K, Kobayashi, T, Williams, FK, Michell, RH (2009) Phosphatidylinositol 3,5-bisphosphate and Fab1p/PIKfyve underPPIn endo-lysosome function. Biochem J 419: pp. 1-13
59. Dowling, JJ, Vreede, AP, Low, SE, Gibbs, EM, Kuwada, JY, Bonnemann, CG, Feldman, EL (2009) Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet 5: pp. 1000372
60. Dowling, JJ, Low, SE, Busta, AS, Feldman, EL (2010) Zebrafish MTMR14 is required for excitation-contraction coupling, developmental motor function and the regulation of autophagy. Hum Mol Genet 19: pp. 2668-2681
61. Duerr, EM, Rollbrocker, B, Hayashi, Y, Peters, N, Meyer-Puttlitz, B, Louis, DN, Schramm, J, Wiestler, OD, Parsons, R, Eng, C, Deimling, A(1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16: pp. 2259-2264
62. Fan, HY, Liu, Z, Cahill, N, Richards, JS (2008) Targeted disruption of Pten in ovarian granulosa cells enhances ovulation and extends the life span of luteal cells. Mol Endocrinol 22: pp. 2128-2140
63. Fares, H, Greenwald, I (2001) Genetic analysis of endocytosis in Caenorhabditis elegans: coelomocyte uptake defective mutants. Genetics 159: pp. 133-145
64. Feng Q, Di R, Tao F, Chang Z, Lu S, Fan W, Shan C, Li X, Yang Z (2010) PDK1 regulates vascular remodeling and promotes epithelial-mesenchymal transition in cardiac development. Mol Cell Biol 30:3711–3721
65. Fili, N, Calleja, V, Woscholski, R, Parker, PJ, Larijani, B (2006) Compartmental signal modulation: endosomal phosphatidylinositol 3-phosphate controls endosome morphology and selective cargo sorting. Proc Natl Acad Sci USA 103: pp. 15473-15478
66. Fine, B, Hodakoski, C, Koujak, S, Su, T, Saal, LH, Maurer, M, Hopkins, B, Keniry, M, Sulis, ML, Mense, S, Hibshoosh, H, Parsons, R (2009) Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science 325: pp. 1261-1265
67. Firestein, R, Nagy, PL, Daly, M, Huie, P, Conti, M, Cleary, ML (2002) Male infertility, impaired spermatogenesis, and azoospermia in mice deficient for the pseudophosphatase Sbf1. J Clin Invest 109: pp. 1165-1172
68. Ford-Hutchinson, AF, Ali, Z, Lines, SE, Hallgrimsson, B, Boyd, SK, Jirik, FR (2007) Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth. J Bone Miner Res 22: pp. 1245-1259
69. Fouladkou, F, Landry, T, Kawabe, H, Neeb, A, Lu, C, Brose, N, Stambolic, V, Rotin, D (2008) The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. Proc Natl Acad Sci USA 105: pp. 8585-8590
70. Fox, JA, Ung, K, Tanlimco, SG, Jirik, FR (2002) Disruption of a single Pten allele augments the chemotactic response of B lymphocytes to stromal cell-derived factor-1. J Immunol 169: pp. 49-54
71. Fraser, MM, Bayazitov, IT, Zakharenko, SS, Baker, SJ (2008) Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. Neuroscience 151: pp. 476-488
72. Freeman, DJ, Li, AG, Wei, G, Li, HH, Kertesz, N, Lesche, R, Whale, AD, Martinez-Diaz, H, Rozengurt, N, Cardiff, RD, Liu, X, Wu, H (2003) PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3: pp. 117-130
73. Fridberg, M, Servin, A, Anagnostaki, L, Linderoth, J, Berglund, M, Soderberg, O, Enblad, G, Rosen, A, Mustelin, T, Jerkeman, M, Persson, JL, Wingren, AG (2007) Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN. Leuk Lymphoma 48: pp. 2221-2232
74. Fruman, DA, Bismuth, G (2009) Fine tuning the immune response with PI3K. Immunol Rev 228: pp. 253-272
75. Funamoto, S, Meili, R, Lee, S, Parry, L, Firtel, RA (2002) Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis. Cell 109: pp. 611-623
76. Furnari, FB, Huang, HJ, Cavenee, WK (1998) The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 58: pp. 5002-5008
77. Gao, P, Wange, RL, Zhang, N, Oppenheim, JJ, Howard, OM (2005) Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN. Blood 106: pp. 2619-2626
78. Gary, DS, Mattson, MP (2002) PTEN regulates Akt kinase activity in hippocampal neurons and increases their sensitivity to glutamate and apoptosis. Neuromolecular Med 2: pp. 261-269
79. Georgescu, MM, Kirsch, KH, Kaloudis, P, Yang, H, Pavletich, NP, Hanafusa, H (2000) Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor. Cancer Res 60: pp. 7033-7038
80. Gil, A, Andres-Pons, A, Fernandez, E, Valiente, M, Torres, J, Cervera, J, Pulido, R (2006) Nuclear localization of PTEN by a Ran-dependent mechanism enhances apoptosis: involvement of an N-terminal nuclear localization domain and multiple nuclear exclusion motifs. Mol Biol Cell 17: pp. 4002-4013
81. Gildea, JJ, Herlevsen, M, Harding, MA, Gulding, KM, Moskaluk, CA, Frierson, HF, Theodorescu, D (2004) PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Oncogene 23: pp. 6788-6797
82. Gillooly, DJ, Morrow, IC, Lindsay, M, Gould, R, Bryant, NJ, Gaullier, J-M, Parton, RG, Stenmark, H (2000) Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. EMBO J 19: pp. 4577-4588
83. Gillooly, DJ, Raiborg, C, Stenmark, H (2003) Phosphatidylinositol 3-phosphate is found in microdomains of early endosomes. Histochem Cell Biol 120: pp. 445-453
84. Ginn-Pease, ME, Eng, C (2003) Increased nuclear phosphatase and tensin homologue deleted on chromosome 10 is associated with G0-G1 in MCF-7 cells. Cancer Res 63: pp. 282-286
85. Gispert, S, Ricciardi, F, Kurz, A, Azizov, M, Hoepken, HH, Becker, D, Voos, W, Leuner, K, Muller, WE, Kudin, AP, Kunz, WS, Zimmermann, A, Roeper, J, Wenzel, D, Jendrach, M, Garcia-Arencibia, M, Fernandez-Ruiz, J, Huber, L, Rohrer, H, Barrera, M, Reichert, AS, Rub, U, Chen, A, Nussbaum, RL, Auburger, G (2009) Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS One 4: pp. 5777
86. Goryunov, D, Nightingale, A, Bornfleth, L, Leung, C, Liem, RK (2008) Multiple disease-linked myotubularin mutations cause NFL assembly defects in cultured cells and disrupt myotubularin dimerization. J Neurochem 104: pp. 1536-1552
87. Griffin, RJ, Moloney, A, Kelliher, M, Johnston, JA, Ravid, R, Dockery, P, O’Connor, R, O’Neill, C (2005) Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer’s disease pathology. J Neurochem 93: pp. 105-117
88. Gronbaek, K, Zeuthen, J, Guldberg, P, Ralfkiaer, E, Hou-Jensen, K (1998) Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood 91: pp. 4388-4390
89. Groszer, M, Erickson R, Scripture-Adams DD, Lesche, R, Trumpp, A, Zack, JA, Kornblum, HI, Liu, X, Wu, H (2001) Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 294: pp. 2186-2189
90. Groszer, M, Erickson R, Scripture-ADAMS, DD, Dougherty, JD, Belle, J, Zack, JA, Geschwind, DH, Liu, X, Kornblum, HI, Wu, H (2006) PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. Proc Natl Acad Sci USA 103: pp. 111-116
91. Gu, J, Tamura, M, Pankov, R, Danen, EH, Takino, T, Matsumoto, K, Yamada, KM (1999) Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 146: pp. 389-403
92. Haas-Kogan, D, Shalev, N, Wong, M, Mills, G, Yount, G, Stokoe, D (1998) Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 8: pp. 1195-1198
93. Hagenbeek, TJ, Spits, H (2008) T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus. Leukemia 22: pp. 608-619
94. Hagenbeek, TJ, Naspetti, M, Malergue, F, Garcon, F, Nunes, JA, Cleutjens, KB, Trapman, J, Krimpenfort, P, Spits, H (2004) The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling. J Exp Med 200: pp. 883-894
95. Hamada, K, Sasaki, T, Koni, PA, Natsui, M, Kishimoto, H, Sasaki, J, Yajima, N, Horie, Y, Hasegawa, G, Naito, M, Miyazaki, J, Suda, T, Itoh, H, Nakao, K, Mak, TW, Nakano, T, Suzuki, A (2005) The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev 19: pp. 2054-2065
96. Han, SY, Kato, H, Kato, S, Suzuki, T, Shibata, H, Ishii, S, Shiiba, K, Matsuno, S, Kanamaru, R, Ishioka, C (2000) Functional evaluation of PTEN missense mutations using in vitro phosphoinositide phosphatase assay. Cancer Res 60: pp. 3147-3151
97. He, L (2010) Posttranscriptional regulation of PTEN dosage by noncoding RNAs. Sci Signal 3: pp. 39
98. He, XC, Yin, T, Grindley, JC, Tian, Q, Sato, T, Tao, WA, Dirisina, R, Porter-Westpfahl, KS, Hembree, M, Johnson, T, Wiedemann, LM, Barrett, TA, Hood, L, Wu, H, Li, L (2007) PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet 39: pp. 189-198
99. He, L, Ingram, A, Rybak, AP, Tang, D (2010) Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells. J Clin Invest 120: pp. 2094-2108
100. Heit, B, Robbins, SM, Downey, CM, Guan, Z, Colarusso, P, Miller, BJ, Jirik, FR, Kubes, P (2008) PTEN functions to ‘prioritize’ chemotactic cues and prevent ‘distraction’ in migrating neutrophils. Nat Immunol 9: pp. 743-752
101. Hernando, E, Charytonowicz, E, Dudas, ME, Menendez, S, Matushansky, I, Mills, J, Socci, ND, Behrendt, N, Ma, L, Maki, RG, Pandolfi, PP, Cordon-Cardo, C (2007) The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas. Nat Med 13: pp. 748-753
102. Hirsch, E, Katanaev, VL, Garlanda, C, Azzolino, O, Pirola, L, Silengo, L, Sozzani, S, Mantovani, A, Altruda, F, Wymann, MP (2000) Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287: pp. 1049-1053
103. Hnia, K, Tronchere, H, Tomczak, KK, Amoasii, L, Schultz, P, Beggs, AH, Payrastre, B, Mandel, JL, Laporte, J (2010) Myotubularin controls desmin intermediate filament architecture and mitochondrial dynamics in human and mouse skeletal muscle. J Clin Invest 121: pp. 70-85
104. Horie, Y, Suzuki, A, Kataoka, E, Sasaki, T, Hamada, K, Sasaki, J, Mizuno, K, Hasegawa, G, Kishimoto, H, Iizuka, M, Naito, M, Enomoto, K, Watanabe, S, Mak, TW, Nakano, T (2004) Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest 113: pp. 1774-1783
105. Iijima, M, Devreotes, P (2002) Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell 109: pp. 599-610
106. Iijima, M, Huang, YE, Luo, HR, Vazquez, F, Devreotes, PN (2004) Novel mechanism of PTEN regulation by its phosphatidylinositol 4,5-bisphosphate binding motif is critical for chemotaxis. J Biol Chem 279: pp. 16606-16613
107. Inoue-Narita, T, Hamada, K, Sasaki, T, Hatakeyama, S, Fujita, S, Kawahara, K, Sasaki, M, Kishimoto, H, Eguchi, S, Kojima, I, Beermann, F, Kimura, T, Osawa, M, Itami, S, Mak, TW, Nakano, T, Manabe, M, Suzuki, A (2008) Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis. Cancer Res 68: pp. 5760-5768
108. Inzelberg, R, Jankovic, J (2007) Are Parkinson disease patients protected from some but not all cancers. Neurology 69: pp. 1542-1550
109. Ji, SP, Zhang, Y, Cleemput, J, Jiang, W, Liao, M, Li, L, Wan, Q, Backstrom, JR, Zhang, X (2006) Disruption of PTEN coupling with 5-HT2 C receptors suppresses behavioral responses induced by drugs of abuse. Nat Med 12: pp. 324-329
110. Jiang, BH, Liu, LZ (2008) PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784: pp. 150-158
111. Kelley, VA, Schorey, JS (2004) Modulation of cellular phosphatidylinositol 3-phosphate levels in primary macrophages affects heat-killed but not viable Mycobacterium avium’s transport through the phagosome maturation process. Cell Microbiol 6: pp. 973-985
112. Kerk, D, Moorhead, GB (2010) A phylogenetic survey of myotubularin genes of eukaryotes: distribution, protein structure, evolution, and gene expression. BMC Evol Biol 10: pp. 196
113. Khan, S, Kumagai, T, Vora, J, Bose, N, Sehgal, I, Koeffler, PH, Bose, S (2004) PTEN promoter is methylated in a proportion of invasive breast cancers. Int J Cancer 112: pp. 407-410
114. Kim, D, Dressler, GR (2007) PTEN modulates GDNF/RET mediated chemotaxis and branching morphogenesis in the developing kidney. Dev Biol 307: pp. 290-299
115. Kim, SK, Su, LK, Oh, Y, Kemp, BL, Hong, WK, Mao, L (1998) Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines. Oncogene 16: pp. 89-93
116. Kim, S-A, Taylor, GS, Torgersen, KM, Dixon, JE (2002) Myotubularin and MTMR2, Phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease. J Biol Chem 277: pp. 4526-4531
117. Kim, S-A, Vacratsis, PO, Firestein, R, Cleary, ML, Dixon, JE (2003) Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase. Proc Natl Acad Sci USA 100: pp. 4492-4497
118. Kim, RH, Smith, PD, Aleyasin, H, Hayley, S, Mount, MP, Pownall, S, Wakeham, A, You-Ten, AJ, Kalia, SK, Horne, P, Westaway, D, Lozano, AM, Anisman, H, Park, DS, Mak, TW (2005) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci USA 102: pp. 5215-5220
119. Kim, JS, Lee, C, Bonifant, CL, Ressom, H, Waldman, T (2007) Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA. Mol Cell Biol 27: pp. 662-677
120. Kim, JW, Kang, KH, Burrola, P, Mak, TW, Lemke, G (2008) Retinal degeneration triggered by inactivation of PTEN in the retinal pigment epithelium. Genes Dev 22: pp. 3147-3157
121. Kimura, T, Suzuki, A, Fujita, Y, Yomogida, K, Lomeli, H, Asada, N, Ikeuchi, M, Nagy, A, Mak, TW, Nakano, T (2003) Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 130: pp. 1691-1700
122. Kishimoto, H, Ohteki, T, Yajima, N, Kawahara, K, Natsui, M, Kawarasaki, S, Hamada, K, Horie, Y, Kubo, Y, Arase, S, Taniguchi, M, Vanhaesebroeck, B, Mak, TW, Nakano, T, Koyasu, S, Sasaki, T, Suzuki, A (2007) The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. Blood 109: pp. 3316-3324
123. Knobbe, CB, Lapin, V, Suzuki, A, Mak, TW (2008) The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey. Oncogene 27: pp. 5398-5415
124. Kohno, T, Takahashi, M, Manda, R, Yokota, J (1998) Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers. Genes Chromosomes Cancer 22: pp. 152-156
125. Korkaya, H, Paulson, A, Charafe-Jauffret, E, Ginestier, C, Brown, M, Dutcher, J, Clouthier, SG, Wicha, MS (2009) Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol 7: pp. 1000121
126. Kotelevets, L, Hengel, J, Bruyneel, E, Mareel, M, Roy, F, Chastre, E (2001) The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness. J Cell Biol 155: pp. 1129-1135
127. Kotelevets, L, Hengel, J, Bruyneel, E, Mareel, M, Roy, F, Chastre, E (2005) Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. Faseb J 19: pp. 115-117
128. Koul, D, Parthasarathy, R, Shen, R, Davies, MA, Jasser, SA, Chintala, SK, Rao, JS, Sun, Y, Benvenisite, EN, Liu, TJ, Yung, WK (2001) Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 20: pp. 6669-6678
129. Kurlawalla-Martinez, C, Stiles, B, Wang, Y, Devaskar, SU, Kahn, BB, Wu, H (2005) Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol Cell Biol 25: pp. 2498-2510
130. Kuroda, S, Nishio, M, Sasaki, T, Horie, Y, Kawahara, K, Sasaki, M, Natsui, M, Matozaki, T, Tezuka, H, Ohteki, T, Forster, I, Mak, TW, Nakano, T, Suzuki, A (2008) Effective clearance of intracellular Leishmania major in vivo requires Pten in macrophages. Eur J Immunol 38: pp. 1331-1340
131. Kwon, CH, Zhu, X, Zhang, J, Knoop, LL, Tharp, R, Smeyne, RJ, Eberhart, CG, Burger, PC, Baker, SJ (2001) Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29: pp. 404-411
132. Kwon, CH, Luikart, BW, Powell, CM, Zhou, J, Matheny, SA, Zhang, W, Li, Y, Baker, SJ, Parada, LF (2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50: pp. 377-388
133. Lacalle, RA, Gomez-Mouton, C, Barber, DF, Jimenez-Baranda, S, Mira, E, Martinez, AC, Carrera, AC, Manes, S (2004) PTEN regulates motility but not directionality during leukocyte chemotaxis. J Cell Sci 117: pp. 6207-6215
134. Laporte, J, Hu, LJ, Kretz, C, Mandel, J.-L., Kioschis, P, Coy, JF, Klauck, SM, Poustka, A, Dahl, N (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 13: pp. 175-182
135. Laporte, J, Blondeau, F, Buj-Bello, A, Tentler, D, Kretz, C, Dahl, N, Mandel, J (1998) Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. Hum Mol Genet 7: pp. 1703-1712
136. Laporte, J, Blondeau, F, Gansmuller, A, Lutz, Y, Vonesch, J-L, Mandel, J-L (2002) The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles. J Cell Sci 115: pp. 3105-3117
137. Laporte, J, Bedez, F, Bolino, A, Mandel, J-L (2003) Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum Mol Genet 12: pp. R285-R292
138. Lee, JO, Yang, H, Georgescu, MM, Cristofano, A, Maehama, T, Shi, Y, Dixon, JE, Pandolfi, P, Pavletich, NP (1999) Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99: pp. 323-334
139. Lee, HW, Kim, Y, Han, K, Kim, H, Kim, E (2010a) The phosphoinositide 3-phosphatase MTMR2 interacts with PSD-95 and maintains excitatory synapses by modulating endosomal traffic. J Neurosci 30: pp. 5508-5518
140. Lee JJ, Kim BC, Park MJ, Lee YS, Kim YN, Lee BL, Lee JS (2011) PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation. Cell Death Differ 18:666–677
141. Leslie, NR, Yang, X, Downes, CP, Weijer, CJ (2007) PtdIns(3,4,5)P3-dependent and -independent roles for PTEN in the control of cell migration. Curr Biol 17: pp. 115-125
142. Leslie, NR, Batty, IH, Maccario, H, Davidson, L, Downes, CP (2008) Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 27: pp. 5464-5476
143. Leslie, NR, Spinelli, L, Tibarewal, P, Zilidis, G, Weerasinghe, N, Lim, JC, Maccario, H, Downes, CP (2010) Indirect mechanisms of carcinogenesis via downregulation of PTEN function. Adv Enzyme Regul 50: pp. 112-118
144. Li, DM, Sun, H (1997) TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 57: pp. 2124-2129
145. Li, DM, Sun, H (1998) PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 95: pp. 15406-15411
146. Li, J, Yen, C, Liaw, D, Podsypanina, K, Bose, S, Wang, SI, Puc, J, Miliaresis, C, Rodgers, L, McCombie, R, Bigner, SH, Giovanella, BC, Ittmann, M, Tycko, B, Hibshoosh, H, Wigler, MH, Parsons, R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: pp. 1943-1947
147. Li, Z, Jiang, H, Xie, W, Zhang, Z, Smrcka, AV, Wu, D (2000) Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. Science 287: pp. 1046-1049
148. Li, G, Robinson, GW, Lesche, R, Martinez-Diaz, H, Jiang, Z, Rozengurt, N, Wagner, KU, Wu, DC, Lane, TF, Liu, X, Hennighausen, L, Wu, H (2002a) Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 129: pp. 4159-4170
149. Li, L, Liu, F, Salmonsen, RA, Turner, TK, Litofsky, NS, Cristofano, A, Pandolfi, PP, Jones, SN, Recht, LD, Ross, AH (2002b) PTEN in neural precursor cells: regulation of migration, apoptosis, and proliferation. Mol Cell Neurosci 20: pp. 21-29
150. Li, Y, Jia, Y, Pichavant, M, Loison, F, Sarraj, B, Kasorn, A, You, J, Robson, BE, Umetsu, DT, Mizgerd, JP, Ye, K, Luo, HR (2009) Targeted deletion of tumor suppressor PTEN augments neutrophil function and enhances host defense in neutropenia-associated pneumonia. Blood 113: pp. 4930-4941
151. Liaw, D, Marsh, DJ, Li, J, Dahia, PL, Wang, SI, Zheng, Z, Bose, S, Call, KM, Tsou, HC, Peacocke, M, Eng, C, Parsons, R (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16: pp. 64-67
152. Liliental, J, Moon, SY, Lesche, R, Mamillapalli, R, Li, D, Zheng, Y, Sun, H, Wu, H (2000) Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Curr Biol 10: pp. 401-404
153. Lin, CH, Yeh, SH, Lu, KT, Leu, TH, Chang, WC, Gean, PW (2001) A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31: pp. 841-851
154. Lin, HK, Chen, Z, Wang, G, Nardella, C, Lee, SW, Chan, CH, Yang, WL, Wang, J, Egia, A, Nakayama, KI, Cordon-Cardo, C, Teruya-Feldstein, J, Pandolfi, PP (2010) Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 464: pp. 374-379
155. Lindsay, Y, McCoull, D, Davidson, L, Leslie, NR, Fairservice, A, Gray, A, Lucocq, J, Downes, CP (2006) Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression. J Cell Sci 119: pp. 5160-5168
156. Liu, H, Radisky, DC, Wang, F, Bissell, MJ (2004) Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 164: pp. 603-612
157. Liu, F, Wagner, S, Campbell, RB, Nickerson, JA, Schiffer, CA, Ross, AH (2005a) PTEN enters the nucleus by diffusion. J Cell Biochem 96: pp. 221-234
158. Liu, JL, Sheng, X, Hortobagyi, ZK, Mao, Z, Gallick, GE, Yung, WK (2005b) Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Mol Cell Biol 25: pp. 6211-6224
159. Liu, X, Shi, Y, Giranda, VL, Luo, Y (2006) Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis. Mol Cancer Ther 5: pp. 494-501
160. Liu, X, Bruxvoort, KJ, Zylstra, CR, Liu, J, Cichowski, R, Faugere, MC, Bouxsein, ML, Wan, C, Williams, BO, Clemens, TL (2007) Lifelong accumulation of bone in mice lacking Pten in osteoblasts. Proc Natl Acad Sci USA 104: pp. 2259-2264
161. Liu, W, Zhou, Y, Reske, SN, Shen, C (2008) PTEN mutation: many birds with one stone in tumorigenesis. Anticancer Res 28: pp. 3613-3619
162. Liu, X, Karnell, JL, Yin, B, Zhang, R, Zhang, J, Li, P, Choi, Y, Maltzman, JS, Pear, WS, Bassing, CH, Turka, LA (2010) Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice. J Clin Invest 120: pp. 2497-2507
163. Lorenzo, O, Urbe, S, Clague, MJ (2005) Analysis of phosphoinositide binding domain properties within the myotubularin-related protein MTMR3. J Cell Sci 118: pp. 2005-2012
164. Lorenzo, O, Urbe, S, Clague, MJ (2006) Systematic analysis of myotubularins: heteromeric interactions, subcellular localisation and endosome related functions. J Cell Sci 119: pp. 2953-2959
165. Lu, Y, Liu, JH, Zhang, J, Wang, H, Koul, D, McMurray, JS, Fang, X, Yung, WK, Siminovitch, KA, Mills, GB (2003) Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J Biol Chem 278: pp. 40057-40066
166. Ma, X, Made, AC, Autar, B, Van der Korput, HA, Vermeij, M, Duijn, P, Cleutjens, KB, De Krijger, R, Krimpenfort, P, Berns, A, Kwast, TH, Trapman, J (2005) Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Cancer Res 65: pp. 5730-5739
167. Maccario, H, Perera, NM, Davidson, L, Downes, CP, Leslie, NR (2007) PTEN is destabilized by phosphorylation on Thr366. Biochem J 405: pp. 439-444
168. Maccario, H, Perera, NM, Gray, A, Downes, CP, Leslie, NR (2010) Ubiquitination of PTEN (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress. J Biol Chem 285: pp. 12620-12628
169. Maehama, T, Dixon, JE (1998) The Tumor Suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: pp. 13375-13378
170. Mahimainathan, L, Choudhury, GG (2004) Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. J Biol Chem 279: pp. 15258-15268
171. Marino, S, Krimpenfort, P, Leung, C, Van Der Korput, HA, Trapman, J, Camenisch, I, Berns, A, Brandner, S (2002) PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development 129: pp. 3513-3522
172. Marsh, DJ, Dahia, PL, Zheng, Z, Liaw, D, Parsons, R, Gorlin, RJ, Eng, C (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16: pp. 333-334
173. Marsh, DJ, Coulon, V, Lunetta, KL, Rocca-Serra, P, Dahia, PL, Zheng, Z, Liaw, D, Caron, S, Duboue, B, Lin, AY, Richardson, AL, Bonnetblanc, JM, Bressieux, JM, Cabarrot-Moreau, A, Chompret, A, Demange, L, Eeles, RA, Yahanda, AM, Fearon, ER, Fricker, JP, Gorlin, RJ, Hodgson, SV, Huson, S, Lacombe, D, Eng, C (1998) Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 7: pp. 507-515
174. Marsh, V, Winton, DJ, Williams, GT, Dubois, N, Trumpp, A, Sansom, OJ, Clarke, AR (2008) Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation. Nat Genet 40: pp. 1436-1444
175. Martin-Belmonte, F, Gassama, A, Datta, A, Yu, W, Rescher, U, Gerke, V, Mostov, K (2007) PTEN-mediated apical segregation of phosphoinositides controls epithelial morphogenesis through Cdc42. Cell 128: pp. 383-397
176. Mayo, LD, Donner, DB (2001) A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc Natl Acad Sci USA 98: pp. 11598-11603
177. McConnachie, G, Pass, I, Walker, SM, Downes, CP (2003) Interfacial kinetic analysis of the tumour suppressor phosphatase, PTEN: evidence for activation by anionic phospholipids. Biochem J 371: pp. 947-955
178. Mei, J, Liu, S, Li, Z, Gui, JF (2010) Mtmr8 is essential for vasculature development in zebrafish embryos. BMC Dev Biol 10: pp. 96
179. Miletic AV, Anzelon-Mills AN, Mills DM, Omori SA, Pedersen IM, Shin DM, Ravetch JV, Bolland S, Morse HC 3RD, Rickert RC (2010) Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases. J Exp Med 207:2407–2420
180. Mirmohammadsadegh, A, Marini, A, Nambiar, S, Hassan, M, Tannapfel, A, Ruzicka, T, Hengge, UR (2006) Epigenetic silencing of the PTEN gene in melanoma. Cancer Res 66: pp. 6546-6552
181. Mochizuki, Y, Majerus, PW (2003) Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9. Proc Natl Acad Sci USA 100: pp. 9768-9773
182. Mutter, GL, Lin, MC, Fitzgerald, JT, Kum, JB, Baak, JP, Lees, JA, Weng, LP, Eng, C (2000) Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92: pp. 924-930
183. Myers, MP, Stolarov, JP, Eng, C, Li, J, Wang, SI, Wigler, MH, Parsons, R, Tonks, NK (1997) P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci USA 94: pp. 9052-9057
184. Myers, MP, Pass, I, Batty, IH, Van Der Kaay, J, Stolarov, JP, Hemmings, BA, Wigler, MH, Downes, CP, Tonks, NK (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95: pp. 13513-13518
185. Nandurkar, HH, Caldwell, KK, Whisstock, JC, Layton, MJ, Gaudet, EA, Norris, FA, Majerus, PW, Mitchell, CA (2001) Characterization of an adapter subunit to a phosphatidylinositol (3)P 3-phosphatase: Identification of a myotubularin-related protein lacking catalytic activity. Proc Natl Acad Sci USA 98: pp. 9499-9504
186. Nandurkar, HH, Layton, M, Laporte, J, Selan, C, Corcoran, L, Caldwell, KK, Mochizuki, Y, Majerus, PW, Mitchell, CA (2003) Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. Proc Natl Acad Sci USA 100: pp. 8660-8665
187. Naughtin, MJ, Sheffield, DA, Rahman, P, Hughes, WE, Gurung, R, Stow, JL, Nandurkar, HH, Dyson, JM, Mitchell, CA (2010) The myotubularin phosphatase MTMR4 regulates sorting from early endosomes. J Cell Sci 123: pp. 3071-3083
188. Nemenoff, RA, Simpson, PA, Furgeson, SB, Kaplan-Albuquerque, N, Crossno, J, Garl, PJ, Cooper, J, Weiser-evans, MC (2008) Targeted deletion of PTEN in smooth muscle cells results in vascular remodeling and recruitment of progenitor cells through induction of stromal cell-derived factor-1alpha. Circ Res 102: pp. 1036-1045
189. Nguyen, KT, Tajmir, P, Lin, CH, Liadis, N, Zhu, XD, Eweida, M, Tolasa-Karaman, G, Cai, F, Wang, R, Kitamura, T, Belsham, DD, Wheeler, MB, Suzuki, A, Mak, TW, Woo, M (2006) Essential role of Pten in body size determination and pancreatic beta-cell homeostasis in vivo. Mol Cell Biol 26: pp. 4511-4518
190. Ning, K, Pei, L, Liao, M, Liu, B, Zhang, Y, Jiang, W, Mielke, JG, Li, L, Chen, Y, El-Hayek, YH, Fehlings, MG, Zhang, X, Liu, F, Eubanks, J, Wan, Q (2004) Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. J Neurosci 24: pp. 4052-4060
191. Nishio, M, Watanabe, K, Sasaki, J, Taya, C, Takasuga, S, Iizuka, R, Balla, T, Yamazaki, M, Watanabe, H, Itoh, R, Kuroda, S, Horie, Y, Forster, I, Mak, TW, Yonekawa, H, Penninger, JM, Kanaho, Y, Suzuki, A, Sasaki, T (2007) Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1. Nat Cell Biol 9: pp. 36-44
192. Nogueira, V, Park, Y, Chen, CC, Xu, PZ, Chen, ML, Tonic, I, Unterman, T, Hay, N (2008) Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14: pp. 458-470
193. Oak, JS, Deane, JA, Kharas, MG, Luo, J, Lane, TE, Cantley, LC, Fruman, DA (2006) Sjogren’s syndrome-like disease in mice with T cells lacking class 1A phosphoinositide-3-kinase. Proc Natl Acad Sci USA 103: pp. 16882-16887
194. Odriozola, L, Singh, G, Hoang, T, Chan, AM (2007) Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J Biol Chem 282: pp. 23306-23315
195. Ogawa, S, Kwon, CH, Zhou, J, Koovakkattu, D, Parada, LF, Sinton, CM (2007) A seizure-prone phenotype is associated with altered free-running rhythm in Pten mutant mice. Brain Res 1168: pp. 112-123
196. Okahara, F, Ikawa, H, Kanaho, Y, Maehama, T (2004) Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. J Biol Chem 279: pp. 45300-45303
197. Okahara, F, Itoh, K, Nakagawara, A, Murakami, M, Kanaho, Y, Maehama, T (2006) Critical role of PICT-1, a tumor suppressor candidate, in phosphatidylinositol 3,4,5-trisphosphate signals and tumorigenic transformation. Mol Biol Cell 17: pp. 4888-4895
198. Okumura, K, Mendoza, M, Bachoo, RM, Depinho, RA, Cavenee, WK, Furnari, FB (2006) PCAF modulates PTEN activity. J Biol Chem 281: pp. 26562-26568
199. Omary, MB, Coulombe, PA, McLean, WH (2004) Intermediate filament proteins and their associated diseases. N Engl J Med 351: pp. 2087-2100
200. Omori, N, Jin, G, Li, F, Zhang, WR, Wang, SJ, Hamakawa, Y, Nagano, I, Manabe, Y, Shoji, M, Abe, K (2002) Enhanced phosphorylation of PTEN in rat brain after transient middle cerebral artery occlusion. Brain Res 954: pp. 317-322
201. Park, KK, Liu, K, Hu, Y, Smith, PD, Wang, C, Cai, B, Xu, B, Connolly, L, Kramvis, I, Sahin, M, He, Z (2008) Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322: pp. 963-966
202. Perren, A, Komminoth, P, Saremaslani, P, Matter, C, Feurer, S, Lees, JA, Heitz, PU, Eng, C (2000) Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol 157: pp. 1097-1103
203. Pinal, N, Goberdhan, DC, Collinson, L, Fujita, Y, Cox, IM, Wilson, C, Pichaud, F (2006) Regulated and polarized PtdIns(3,4,5)P3 accumulation is essential for apical membrane morphogenesis in photoreceptor epithelial cells. Curr Biol 16: pp. 140-149
204. Plant, PJ, Correa, J, Goldenberg, N, Bain, J, Batt, J (2009) The inositol phosphatase MTMR4 is a novel target of the ubiquitin ligase Nedd4. Biochem J 419: pp. 57-63
205. Plum, L, Ma, X, Hampel, B, Balthasar, N, Coppari, R, Munzberg, H, Shanabrough, M, Burdakov, D, Rother, E, Janoschek, R, Alber, J, Belgardt, BF, Koch, L, Seibler, J, Schwenk, F, Fekete, C, Suzuki, A, Mak, TW, Krone, W, Horvath, TL, Ashcroft, FM, Bruning, JC (2006) Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. J Clin Invest 116: pp. 1886-1901
206. Podsypanina, K, Ellenson, LH, Nemes, A, Gu, J, Tamura, M, Yamada, KM, Cordon-Cardo, C, Catoretti, G, Fisher, PE, Parsons, R (1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 96: pp. 1563-1568
207. Poliseno, L, Salmena, L, Riccardi, L, Fornari, A, Song, MS, Hobbs, RM, Sportoletti, P, Varmeh, S, Egia, A, Fedele, G, Rameh, L, Loda, M, Pandolfi, PP (2010a) Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal 3: pp. 29
208. Poliseno, L, Salmena, L, Zhang, J, Carver, B, Haveman, WJ, Pandolfi, PP (2010b) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465: pp. 1033-1038
209. Pollard, SM, Yoshikawa, K, Clarke, ID, Danovi, D, Stricker, S, Russell, R, Bayani, J, Head, R, Lee, M, Bernstein, M, Squire, JA, Smith, A, Dirks, P (2009) Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4: pp. 568-580
210. Pridgeon JW, Olzmann JA, Chin LS, Li L (2007) PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 5:e172
211. Puzio-Kuter, AM, Castillo-Martin, M, Kinkade, CW, Wang, X, Shen, TH, Matos, T, Shen, MM, Cordon-Cardo, C, Abate-Shen, C (2009) Inactivation of p53 and Pten promotes invasive bladder cancer. Genes Dev 23: pp. 675-680
212. Qiu, W, Federico, L, Naples, M, Avramoglu, RK, Meshkani, R, Zhang, J, Tsai, J, Hussain, M, Dai, K, Iqbal, J, Kontos, CD, Horie, Y, Suzuki, A, Adeli, K (2008) Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins. Hepatology 48: pp. 1799-1809
213. Raftopoulou, M, Etienne-Manneville, S, Self, A, Nicholls, S, Hall, A (2004) Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303: pp. 1179-1181
214. Rahdar, M, Inoue, T, Meyer, T, Zhang, J, Vazquez, F, Devreotes, PN (2009) A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc Natl Acad Sci USA 106: pp. 480-485
215. Ratnacaram, CK, Teletin, M, Jiang, M, Meng, X, Chambon, P, Metzger, D (2008) Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma. Proc Natl Acad Sci USA 105: pp. 2521-2526
216. Reddy, P, Liu, L, Adhikari, D, Jagarlamudi, K, Rajareddy, S, Shen, Y, Du, C, Tang, W, Hamalainen, T, Peng, SL, Lan, ZJ, Cooney, AJ, Huhtaniemi, I, Liu, K (2008) Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science 319: pp. 611-613
217. Robinson, FL, Dixon, JE (2005) The Phosphoinositide-3-phosphatase MTMR2 Associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth disease. J Biol Chem 280: pp. 31699-31707
218. Robinson, FL, Dixon, JE (2006) Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol 16: pp. 403
219. Robinson, FL, Niesman, IR, Beiswenger, KK, Dixon, JE (2008) Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice. Proc Natl Acad Sci USA 105: pp. 4916-4921
220. Romero-Suarez, S, Shen, J, Brotto, L, Hall, T, Mo, C, Valdivia, HH, Andresen, J, Wacker, M, Nosek, TM, Qu, CK, Brotto, M (2010) Muscle-specific inositide phosphatase (MIP/MTMR14) is reduced with age and its loss accelerates skeletal muscle aging process by altering calcium homeostasis. Aging, Albany NY
221. Rossi, DJ, Weissman, IL (2006) Pten, tumorigenesis, and stem cell self-renewal. Cell 125: pp. 229-231
222. Ruckle, T, Schwarz, MK, Rommel, C (2006) PI3Kgamma inhibition: towards an ‘aspirin of the 21st century’. Nat Rev Drug Discov 5: pp. 903-918
223. Sagona, AP, Nezis, IP, Pedersen, NM, Liestol, K, Poulton, J, Rusten, TE, Skotheim, RI, Raiborg, C, Stenmark, H (2010) PtdIns(3)P controls cytokinesis through KIF13A-mediated recruitment of FYVE-CENT to the midbody. Nat Cell Biol 12: pp. 362-371
224. Salmena, L, Carracedo, A, Pandolfi, PP (2008) Tenets of PTEN tumor suppression. Cell 133: pp. 403-414
225. Salvesen, HB, Stefansson, I, Kretzschmar, EI, Gruber, P, Macdonald, ND, Ryan, A, Jacobs, IJ, Akslen, LA, Das, S (2004) Significance of PTEN alterations in endometrial carcinoma: a population-based study of mutations, promoter methylation and PTEN protein expression. Int J Oncol 25: pp. 1615-1623
226. Sansal, I, Sellers, WR (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22: pp. 2954-2963
227. Santoro, M, Modoni, A, Masciullo, M, Gidaro, T, Broccolini, A, Ricci, E, Tonali, PA, Silvestri, G (2010) Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2). Exp Mol Pathol 89: pp. 158-168
228. Sarquis, MS, Agrawal, S, Shen, L, Pilarski, R, Zhou, XP, Eng, C (2006) Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Hum Genet 79: pp. 23-30
229. Sasaki, T, Irie-sasaki, J, Jones, RG, Oliveira-Dos-Santos, AJ, Stanford, WL, Bolon, B, Wakeham, A, Itie, A, Bouchard, D, Kozieradzki, I, Joza, N, Mak, TW, Ohashi, PS, Suzuki, A, Penninger, JM (2000) Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 287: pp. 1040-1046
230. Sasaki, T, Takasuga, S, Sasaki, J, Kofuji, S, Eguchi, S, Yamazaki, M, Suzuki, A (2009) Mammalian phosphoinositide kinases and phosphatases. Prog Lipid Res 48: pp. 307-343
231. Schaletzky, J, Dove, SK, Short, B, Lorenzo, O, Clague, MJ, Barr, FA (2003) Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases. Curr Biol 13: pp. 504-509
232. Senderek, J, Bergmann, C, Weber, S, Ketelsen, U-P, Schorle, H, Rudnik-Schoneborn, S, Buttner, R, Buchheim, E, Zerres, K (2003) Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet 12: pp. 349-356
233. Sharrard, RM, Maitland, NJ (2000) Alternative splicing of the human PTEN/MMAC1/TEP1 gene. Biochim Biophys Acta 1494: pp. 282-285
234. Shen, WH, Balajee, AS, Wang, J, Wu, H, Eng, C, Pandolfi, PP, Yin, Y (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128: pp. 157-170
235. Shen, J, Brotto, M, Scherman, JA, Guo, C, Stoddard, C, Nosek, TM, Valdivia, HH, Qu, CK (2009) Deficiency of MIP/MTMR14 phosphatase induces a muscle disorder by disrupting Ca(2+) homeostasis. Nat Cell Biol 11: pp. 769-776
236. Shendelman, S, Jonason, A, Martinat, C, Leete, T, Abeliovich, A (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2: pp. 362
237. Silhankova, M, Port, F, Harterink, M, Basler, K, Korswagen, HC (2010) Wnt signalling requires MTM-6 and MTM-9 myotubularin lipid-phosphatase function in Wnt-producing cells. EMBO J 29: pp. 4094-4105
238. Song, MS, Salmena, L, Carracedo, A, Egia, A, Lo-Coco, F, Teruya-Feldstein, J, Pandolfi, PP (2008) The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455: pp. 813-817
239. Song, LB, Li, J, Liao, WT, Feng, Y, Yu, CP, Hu, LJ, Kong, QL, Xu, LH, Zhang, X, Liu, WL, Li, MZ, Zhang, L, Kang, TB, Fu, LW, Huang, WL, Xia, YF, Tsao, SW, Li, M, Band, V, Band, H, Shi, QH, Zeng, YX, Zeng, MS (2009) The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: pp. 3626-3636
240. Srivastava, S, Li, Z, Lin, L, Liu, G, Ko, K, Coetzee, WA, Skolnik, EY (2005) The phosphatidylinositol 3-phosphate phosphatase myotubularin-related protein 6 (MTMR6) is a negative regulator of the Ca2+-Activated K+Channel KCa3.1. Mol Cell Biol 25: pp. 3630-3638
241. Srivastava, S, Ko, K, Choudhury, P, Li, Z, Johnson, AK, Nadkarni, V, Unutmaz, D, Coetzee, WA, Skolnik, EY (2006) Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4T cells. Mol Cell Biol 26: pp. 5595-5602
242. Stambolic, V, Suzuki, A, Pompa, JL, Brothers, GM, Mirtsos, C, Sasaki, T, Ruland, J, Penninger, JM, Siderovski, DP, Mak, TW (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: pp. 29-39
243. Stambolic, V, Macpherson, D, Sas, D, Lin, Y, Snow, B, Jang, Y, Benchimol, S, Mak, TW (2001) Regulation of PTEN transcription by p53. Mol Cell 8: pp. 317-325
244. Stanger, BZ, Stiles, B, Lauwers, GY, Bardeesy, N, Mendoza, M, Wang, Y, Greenwood, A, Cheng, KH, McLaughlin, M, Brown, D, Depinho, RA, Wu, H, Melton, DA, Dor, Y (2005) Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 8: pp. 185-195
245. Steck, PA, Pershouse, MA, Jasser, SA, Yung, WK, Lin, H, Ligon, AH, Langford, LA, Baumgard, ML, Hattier, T, Davis, T, Frye, C, Hu, R, Swedlund, B, Teng, DH, Tavtigian, SV (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: pp. 356-362
246. Stiles, B, Wang, Y, Stahl, A, Bassilian, S, Lee, WP, Kim, YJ, Sherwin, R, Devaskar, S, Lesche, R, Magnuson, MA, Wu, H (2004) Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity [corrected]. Proc Natl Acad Sci USA 101: pp. 2082-2087
247. Stiles, BL, Kuralwalla-Martinez, C, Guo, W, Gregorian, C, Wang, Y, Tian, J, Magnuson, MA, Wu, H (2006) Selective deletion of Pten in pancreatic beta cells leads to increased islet mass and resistance to STZ-induced diabetes. Mol Cell Biol 26: pp. 2772-2781
248. Subramanian, KK, Jia, Y, Zhu, D, Simms, BT, Jo, H, Hattori, H, You, J, Mizgerd, JP, Luo, HR (2007) Tumor suppressor PTEN is a physiologic suppressor of chemoattractant-mediated neutrophil functions. Blood 109: pp. 4028-4037
249. Suzuki, A, Pompa, JL, Stambolic, V, Elia, AJ, Sasaki, T, Del Barco Barrantes, I, Ho, A, Wakeham, A, Itie, A, Khoo, W, Fukumoto, M, Mak, TW(1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8: pp. 1169-1178
250. Suzuki, A, Yamaguchi, MT, Ohteki, T, Sasaki, T, Kaisho, T, Kimura, Y, Yoshida, R, Wakeham, A, Higuchi, T, Fukumoto, M, Tsubata, T, Ohashi, PS, Koyasu, S, Penninger, JM, Nakano, T, Mak, TW (2001) T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14: pp. 523-534
251. Suzuki, A, Itami, S, Ohishi, M, Hamada, K, Inoue, T, Komazawa, N, Senoo, H, Sasaki, T, Takeda, J, Manabe, M, Mak, TW, Nakano, T (2003a) Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res 63: pp. 674-681
252. Suzuki, A, Kaisho, T, Ohishi, M, Tsukio-Yamaguchi, M, Tsubata, T, Koni, PA, Sasaki, T, Mak, TW, Nakano, T (2003b) Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med 197: pp. 657-667
253. Suzuki, A, Nakano, T, Mak, TW, Sasaki, T (2008) Portrait of PTEN: messages from mutant mice. Cancer Sci 99: pp. 209-213
254. Taguchi-Atarashi, N, Hamasaki, M, Matsunaga, K, Omori, H, Ktistakis, NT, Yoshimori, T, Noda, T (2010) Modulation of local Ptdins3P levels by the PI phosphatase MTMR3 regulates constitutive autophagy. Traffic 11: pp. 468-478
255. Tamura, M, Gu, J, Matsumoto, K, Aota, S, Parsons, R, Yamada, KM (1998) Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: pp. 1614-1617
256. Tamura, M, Gu, J, Danen, EH, Takino, T, Miyamoto, S, Yamada, KM (1999a) PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 274: pp. 20693-20703
257. Tamura, M, Gu, J, Takino, T, Yamada, KM (1999b) Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res 59: pp. 442-449
258. Taylor, GS, Maehama, T, Dixon, JE (2000a) Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci USA 97: pp. 8910-8915
259. Taylor, V, Wong, M, Brandts, C, Reilly, L, Dean, NM, Cowsert, LM, Moodie, S, Stokoe, D (2000b) 5¢ phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells. Mol Cell Biol 20: pp. 6860-6871
260. Taylor, BS, Schultz, N, Hieronymus, H, Gopalan, A, Xiao, Y, Carver, BS, Arora, VK, Kaushik, P, Cerami, E, Reva, B, Antipin, Y, Mitsiades, N, Landers, T, Dolgalev, I, Major, JE, Wilson, M, Socci, ND, Lash, AE, Heguy, A, Eastham, JA, Scher, HI, Reuter, VE, Scardino, PT, Sander, C, Sawyers, CL, Gerald, WL (2010) Integrative genomic profiling of human prostate cancer. Cancer Cell 18: pp. 11-22
261. Teng, Y, Sun, AN, Pan, XC, Yang, G, Yang, LL, Wang, MR, Yang, X (2006) Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse. Cancer Res 66: pp. 6972-6981
262. Tersar, K, Boentert, M, Berger, P, Bonneick, S, Wessig, C, Toyka, KV, Young, P, Suter, U (2007) Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2. Hum Mol Genet 16: pp. 2991-3001
263. Tolkacheva, T, Boddapati, M, Sanfiz, A, Tsuchida, K, Kimmelman, AC, Chan, AM (2001) Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383. Cancer Res 61: pp. 4985-4989
264. Tong, Z, Fan, Y, Zhang, W, Xu, J, Cheng, J, Ding, M, Deng, H (2009) Pancreas-specific Pten deficiency causes partial resistance to diabetes and elevated hepatic AKT signaling. Cell Res 19: pp. 710-719
265. Tooze, SA, Yoshimori, T (2010) The origin of the autophagosomal membrane. Nat Cell Biol 12: pp. 831-835
266. Torres, J, Pulido, R (2001) The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J Biol Chem 276: pp. 993-998
267. Tosch, V, Rohde, HM, Tronchere, H, Zanoteli, E, Monroy, N, Kretz, C, Dondaine, N, Payrastre, B, Mandel, JL, Laporte, J (2006) A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy. Hum Mol Genet 15: pp. 3098-3106
268. Toussaint, A, Cowling, BS, Hnia, K, Mohr, M, Oldfors, A, Schwab, Y, Yis, U, Maisonobe, T, Stojkovic, T, Wallgren-Pettersson, C, Laugel, V, Echaniz-Laguna, A, Mandel, JL, Nishino, I, Laporte, J (2010) Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies. Acta Neuropathol 121: pp. 253-266
269. Trimboli, AJ, Cantemir-Stone, CZ, Li, F, Wallace, JA, Merchant, A, Creasap, N, Thompson, JC, Caserta, E, Wang, H, Chong, JL, Naidu, S, Wei, G, Sharma, SM, Stephens, JA, Fernandez, SA, Gurcan, MN, Weinstein, MB, Barsky, SH, Yee, L, Rosol, TJ, Stromberg, PC, Robinson, ML, Pepin, F, Hallett, M, Park, M, Ostrowski, MC, Leone, G (2009) Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461: pp. 1084-1091
270. Tronchere, H, Laporte, J, Pendaries, C, Chaussade, C, Liaubet, L, Pirola, L, Mandel, JL, Payrastre, B (2004) Production of phosphatidylinositol 5-phosphate by the phosphoinositide 3-phosphatase myotubularin in mammalian cells. J Biol Chem 279: pp. 7304-7312
271. Trotman, LC, Niki, M, Dotan, ZA, Koutcher, JA, Cristofano, A, Xiao, A, Khoo, AS, Roy-Burman, P, Greenberg, NM, Dyke, T, Cordon-Cardo, C, Pandolfi, PP (2003) Pten dose dictates cancer progression in the prostate. Plos Biol 1: pp. 59
272. Trotman, LC, Wang, X, Alimonti, A, Chen, Z, Teruya-Feldstein, J, Yang, H, Pavletich, NP, Carver, BS, Cordon-Cardo, C, Erdjument-Bromage, H, Tempst, P, Chi, SG, Kim, HJ, Misteli, T, Jiang, X, Pandolfi, PP (2007) Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128: pp. 141-156
273. Tsuchiya, KD, Wiesner, G, Cassidy, SB, Limwongse, C, Boyle, JT, Schwartz, S (1998) Deletion 10q23.2-q23.33 in a patient with gastrointestinal juvenile polyposis and other features of a Cowden-like syndrome. Genes Chromosomes Cancer 21: pp. 113-118
274. Tsujita, K, Itoh, T, Ijuin, T, Yamamoto, A, Shisheva, A, Laporte, J, Takenawa, T (2004) Myotubularin regulates the function of the late endosome through the GRAM domain-phosphatidylinositol 3,5-bisphosphate interaction. J Biol Chem 279: pp. 13817-13824
275. Tsuruta, H, Kishimoto, H, Sasaki, T, Horie, Y, Natsui, M, Shibata, Y, Hamada, K, Yajima, N, Kawahara, K, Sasaki, M, Tsuchiya, N, Enomoto, K, Mak, TW, Nakano, T, Habuchi, T, Suzuki, A (2006) Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients. Cancer Res 66: pp. 8389-8396
276. Ueda T, Sasaki M, Elia AJ, Chio II, Hamada K, Fukunaga R, Mak TW (2010) Combined deficiency for MAP kinase-interacting kinase 1 and 2 (Mnk1 and Mnk2) delays tumor development. Proc Natl Acad Sci USA 107:13984–13990
277. Valente, EM, Salvi, S, Ialongo, T, Marongiu, R, Elia, AE, Caputo, V, Romito, L, Albanese, A, Dallapiccola, B, Bentivoglio, AR (2004) PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 56: pp. 336-341
278. Van der Vegt, JP, Nuenen, BF, Bloem, BR, Klein, C, Siebner, HR (2009) Imaging the impact of genes on Parkinson’s disease. Neuroscience 164: pp. 191-204
279. Vazquez, F, Ramaswamy, S, Nakamura, N, Sellers, WR (2000) Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20: pp. 5010-5018
280. Vazquez, F, Grossman, SR, Takahashi, Y, Rokas, MV, Nakamura, N, Sellers, WR (2001) Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem 276: pp. 48627-48630
281. Vazquez, F, Matsuoka, S, Sellers, WR, Yanagida, T, Ueda, M, Devreotes, PN (2006) Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. Proc Natl Acad Sci USA 103: pp. 3633-3638
282. Velichkova, M, Juan, J, Kadandale, P, Jean, S, Ribeiro, I, Raman, V, Stefan, C, Kiger, AA (2010) Drosophila Mtm and class II PI3K coregulate a PI(3)P pool with cortical and endolysosomal functions. J Cell Biol 190: pp. 407-425
283. Vergne, I, Roberts, E, Elmaoued, RA, Tosch, V, Delgado, MA, Proikas-Cezanne, T, Laporte, J, Deretic, V (2009) Control of autophagy initiation by phosphoinositide 3-phosphatase Jumpy. EMBO J 28: pp. 2244-2258
284. Verhaak, RG, Hoadley, KA, Purdom, E, Wang, V, Qi, Y, Wilkerson, MD, Miller, CR, Ding, L, Golub, T, Mesirov, JP, Alexe, G, Lawrence, M, O’Kelly, M, Tamayo, P, Weir, BA, Gabriel, S, Winckler, W, Gupta, S, Jakkula, L, Feiler, HS, Hodgson, JG, James, CD, Sarkaria, JN, Brennan, C, Kahn, A, Spellman, PT, Wilson, RK, Speed, TP, Gray, JW, Meyerson, M, Getz, G, Perou, CM, Hayes, DN (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: pp. 98-110
285. Vieira, OV, Harrison, RE, Scott, CC, Stenmark, H, Alexander, D, Liu, J, Gruenberg, J, Schreiber, AD, Grinstein, S (2004) Acquisition of Hrs, an essential component of phagosomal maturation, is impaired by mycobacteria. Mol Cell Biol 24: pp. 4593-4604
286. Stein, W, Ramrath, A, Grimm, A, Muller-Borg, M, Wodarz, A (2005) Direct association of Bazooka/PAR-3 with the lipid phosphatase PTEN reveals a link between the PAR/aPKC complex and phosphoinositide signaling. Development 132: pp. 1675-1686
287. Waite, KA, Eng, C (2002) Protean PTEN: form and function. Am J Hum Genet 70: pp. 829-844
288. Walker, DM, Urbe, S, Dove, SK, Tenza, D, Raposo, G, Clague, MJ (2001) Characterization of MTMR3, an inositol lipid 3-phosphatase with novel substrate specificity. Curr Biol 11: pp. 1600-1605
289. Walker, SM, Leslie, NR, Perera, NM, Batty, IH, Downes, CP (2004) The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif. Biochem J 379: pp. 301-307
290. Wang, S, Gao, J, Lei, Q, Rozengurt, N, Pritchard, C, Jiao, J, Thomas, GV, Li, G, Roy-Burman, P, Nelson, PS, Liu, X, Wu, H (2003) Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4: pp. 209-221
291. Wang, X, Trotman, LC, Koppie, T, Alimonti, A, Chen, Z, Gao, Z, Wang, J, Erdjument-Bromage, H, Tempst, P, Cordon-Cardo, C, Pandolfi, PP, Jiang, X (2007) NEDD4–1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128: pp. 129-139
292. Wang, X, Shi, Y, Wang, J, Huang, G, Jiang, X (2008) Crucial role of the C-terminus of PTEN in antagonizing NEDD4–1-mediated PTEN ubiquitination and degradation. Biochem J 414: pp. 221-229
293. Watton, SJ, Downward, J (1999) Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction. Curr Biol 9: pp. 433-436
294. Whang, YE, Wu, X, Suzuki, H, Reiter, RE, Tran, C, Vessella, RL, Said, JW, Isaacs, WB, Sawyers, CL (1998) Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95: pp. 5246-5250
295. Wijesekara, N, Konrad, D, Eweida, M, Jefferies, C, Liadis, N, Giacca, A, Crackower, M, Suzuki, A, Mak, TW, Kahn, CR, Klip, A, Woo, M (2005) Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol Cell Biol 25: pp. 1135-1145
296. Wu, DN, Pei, DS, Wang, Q, Zhang, GY (2006) Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3-K/Akt during cerebral ischemia in rat hippocampus. Neurosci Lett 404: pp. 98-102
297. Xiao, C, Srinivasan, L, Calado, DP, Patterson, HC, Zhang, B, Wang, J, Henderson, JM, Kutok, JL, Rajewsky, K (2008) Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol 9: pp. 405-414
298. Xue, Y, Fares, H, Grant, B, Li, Z, Rose, AM, Clark, SG, Skolnik, EY (2003) Genetic analysis of the myotubularin family of phosphatases in Caenorhabditis elegans. J Biol Chem 278: pp. 34380-34386
299. Xue, L, Nolla, H, Suzuki, A, Mak, TW, Winoto, A (2008) Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice. Proc Natl Acad Sci USA 105: pp. 2022-2027
300. Yanagi, S, Kishimoto, H, Kawahara, K, Sasaki, T, Sasaki, M, Nishio, M, Yajima, N, Hamada, K, Horie, Y, Kubo, H, Whitsett, JA, Mak, TW, Nakano, T, Nakazato, M, Suzuki, A (2007) Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest 117: pp. 2929-2940
301. Yanagiya, T, Tanabe, A, Iida, A, Saito, S, Sekine, A, Takahashi, A, Tsunoda, T, Kamohara, S, Nakata, Y, Kotani, K, Komatsu, R, Itoh, N, Mineo, I, Wada, J, Masuzaki, H, Yoneda, M, Nakajima, A, Miyazaki, S, Tokunaga, K, Kawamoto, M, Funahashi, T, Hamaguchi, K, Tanaka, K, Yamada, K, Hanafusa, T, Oikawa, S, Yoshimatsu, H, Nakao, K, Sakata, T, Matsuzawa, Y, Kamatani, N, Nakamura, Y, Hotta, K (2007) Association of single-nucleotide polymorphisms in MTMR9 gene with obesity. Hum Mol Genet 16: pp. 3017-3026
302. Yang, L, Mao, C, Teng, Y, Li, W, Zhang, J, Cheng, X, Li, X, Han, X, Xia, Z, Deng, H, Yang, X (2005) Targeted disruption of Smad4 in mouse epidermis results in failure of hair follicle cycling and formation of skin tumors. Cancer Res 65: pp. 8671-8678
303. Yang, G, Sun, Q, Teng, Y, Li, F, Weng, T, Yang, X (2008) PTEN deficiency causes dyschondroplasia in mice by enhanced hypoxia-inducible factor 1alpha signaling and endoplasmic reticulum stress. Development 135: pp. 3587-3597
304. Yao, XH, Nyomba, BL (2008) Hepatic insulin resistance induced by prenatal alcohol exposure is associated with reduced PTEN and TRB3 acetylation in adult rat offspring. Am J Physiol Regul Integr Comp Physiol 294: pp. R1797-R1806
305. Yeager, N, Klein-Szanto, A, Kimura, S, Cristofano, A (2007) Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. Cancer Res 67: pp. 959-966
306. Yilmaz, OH, Valdez, R, Theisen, BK, Guo, W, Ferguson, DO, Wu, H, Morrison, SJ (2006) Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441: pp. 475-482
307. Yim, EK, Peng, G, Dai, H, Hu, R, Li, K, Lu, Y, Mills, GB, Meric-Bernstam, F, Hennessy, BT, Craven, RJ, Lin, SY (2009) Rak functions as a tumor suppressor by regulating PTEN protein stability and function. Cancer Cell 15: pp. 304-314
308. Yin, Y, Shen, WH (2008) PTEN: a new guardian of the genome. Oncogene 27: pp. 5443-5453
309. Yoo, LI, Liu, DW, Le, VU S, Bronson, RT, Wu, H, Yuan, J (2006) Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner. Cancer Res 66: pp. 1929-1939
310. Yu, J, Pan, L, Qin, X, Chen, H, Xu, Y, Chen, Y, Tang, H (2010) MTMR4 attenuates transforming growth factor beta (TGFbeta) signaling by dephosphorylating R-Smads in endosomes. J Biol Chem 285: pp. 8454-8462
311. Yuan, TL, Cantley, LC (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27: pp. 5497-5510
312. Yue, Q, Groszer, M, Gil, JS, Berk, AJ, Messing, A, Wu, H, Liu, X (2005) PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization. Development 132: pp. 3281-3291
313. Zhang, J, Grindley, JC, Yin, T, Jayasinghe, S, He, XC, Ross, JT, Haug, JS, Rupp, D, Porter-Westpfahl, KS, Wiedemann, LM, Wu, H, Li, L(2006) PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441: pp. 518-522
314. Zhang, QG, Wu, DN, Han, D, Zhang, GY (2007) Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury. FEBS Lett 581: pp. 495-505
315. Zhao, R, Qi, Y, Chen, J, Zhao, ZJ (2001) FYVE-DSP2, a FYVE domain-containing dual specificity protein phosphatase that dephosphorylates phosphotidylinositol 3-phosphate. Exp Cell Res 265: pp. 329-338
316. Zheng, H, Ying, H, Yan, H, Kimmelman, AC, Hiller, DJ, Chen, AJ, Perry, SR, Tonon, G, Chu, GC, Ding, Z, Stommel, JM, Dunn, KL, Wiedemeyer, R, You, MJ, Brennan, C, Wang, YA, Ligon, KL, Wong, WH, Chin, L, Depinho, RA (2008) p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455: pp. 1129-1133
317. Zhou, BP, Liao, Y, Xia, W, Zou, Y, Spohn, B, Hung, MC (2001) HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 3: pp. 973-982
318. Zhou, XP, Loukola, A, Salovaara, R, Nystrom-Lahti, M, Peltomaki, P, Chapelle, A, Aaltonen, LA, Eng, C (2002) PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers. Am J Pathol 161: pp. 439-447
319. Zhou, XP, Waite, KA, Pilarski, R, Hampel, H, Fernandez, MJ, Bos, C, Dasouki, M, Feldman, GL, Greenberg, LA, Ivanovich, J, Matloff, E, Patterson, A, Pierpont, ME, Russo, D, Nassif, NT, Eng, C (2003) Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 73: pp. 404-411
320. Zhou, J, Brugarolas, J, Parada, LF (2009) Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1. Hum Mol Genet 18: pp. 4428-4441
321. Zhu, D, Hattori, H, Jo, H, Jia, Y, Subramanian, KK, Loison, F, You, J, Le, Y, Honczarenko, M, Silberstein, L, Luo, HR (2006a) Deactivation of phosphatidylinositol 3,4,5-trisphosphate/Akt signaling mediates neutrophil spontaneous death. Proc Natl Acad Sci USA 103: pp. 14836-14841
322. Zhu, Y, Hoell, P, Ahlemeyer, B, Krieglstein, J (2006b) PTEN: a crucial mediator of mitochondria-dependent apoptosis. Apoptosis 11: pp. 197-207
323. Zhu, Y, Hoell, P, Ahlemeyer, B, Sure, U, Bertalanffy, H, Krieglstein, J (2007) Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson’s disease. Neurochem Int 50: pp. 507-516
324. Zou, J, Chang, SC, Marjanovic, J, Majerus, PW (2009a) MTMR9 increases MTMR6 enzyme activity, stability, and role in apoptosis. J Biol Chem 284: pp. 2064-2071
325. Zou, W, Lu, Q, Zhao, D, Li, W, Mapes, J, Xie, Y, Wang, X (2009b) Caenorhabditis elegans myotubularin MTM-1 negatively regulates the engulfment of apoptotic cells. PLoS Genet 5: pp. e1000679